What's the (end) point?
Dept of Paediatric Cardiology, Center for Congenital Heart Diseases, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands M.Ploegstra@umcg.nl.
Mark-Jan
MJ
Ploegstra
Dept of Paediatric Cardiology, Center for Congenital Heart Diseases, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Rolf M F
RM
Berger
D065128:Endothelin Receptor Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000628:therapy*; D016040:Lung Transplantation; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use*; D044062:Prostaglandins I / Q000627:therapeutic use*
D065128:Endothelin Receptor Antagonists; D058986:Phosphodiesterase 5 Inhibitors; D044062:Prostaglandins I